Clinical trial EMBER-3 / PILOT415
A Randomized, Open-Label, Phase 3 Study of LY3484356 vs Investigator's Choice of Endocrine Therapy, in Patients with Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated with Endocrine Therapy
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2021-000079-35 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04975308 |
| Last update |